Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Design
  4. Volume 30, Issue 42
  5. Article
Volume 30, Issue 42
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Background

Intestinal dysfunction plays an important role in the clinical progress and prognosis of severe acute pancreatitis (SAP). Qingyi decoction (QYD) has shown beneficial effects on intestinal function recovery, but the prevention actions of the QYD on intestinal paralysis and its mechanism have not been fully explored.

Methods

The possible molecular mechanism was unraveled by network pharmacology, including active ingredients and potential target prediction, as well as GO, KEGG, and REATCOME pathway enrichment analyses. The potential interactions between the main active ingredients of the QYD and core genes were explored by molecular docking. A retrospective cohort study on 137 patients with SAP from Tianjin Nankai Hospital was conducted to evaluate the preventive effect of QYD on intestinal paralysis.

Results

A total of 110 active ingredients in QYD were screened out, and 37 key targets were predicted by network pharmacology. GO, KEGG, and REATCOME enrichment analyses showed that bioinformatics annotation of the hub genes was mainly involved in intestinal epithelial functions and inflammatory response pathways. The main components of QYD possessed good affinity with IL-6, TNF, CASP3, CXCL8, and CRP by molecular docking. Patients who used QYD plus usual care seemed to have fewer intestinal paralysis rates, lower risk of renal insufficiency, ARDS and blood purification therapy, and shorter hospital and ICU stays. The multivariable regression analyses indicated that the mode of nasogastric and enemas administration of QYD ( = 0.010) and timely intervention with QYD ( = 0.045) were the independent protective factors for intestinal paralysis prevention in patients with SAP.

Conclusion

In conclusion, QYD can be used as an effective adjuvant procedure to prevent the occurrence and development of intestinal paralysis in patients with SAP. The mechanisms may be involved in the anti-inflammatory response and maintenance of intestinal epithelial function.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128319149240812103715
2024-09-02
2024-11-21

  • From This Site

    /content/journals/cpd/10.2174/0113816128319149240812103715
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BanksP.A. BollenT.L. DervenisC. GooszenH.G. JohnsonC.D. SarrM.G. TsiotosG.G. VegeS.S. Acute pancreatitis classification working group. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut201362110211110.1136/gutjnl‑2012‑30277923100216
     [Google Scholar]
  2. NesvaderaniM EslickGD VaggD Epidemiology, aetiology and outcomes of acute pancreatitis: A retrospective cohort study.Int J Surg201523Pt A687410.1016/j.ijsu.2015.07.70126384834
     [Google Scholar]
  3. ForsmarkC.E. Swaroop VegeS. WilcoxC.M. Acute pancreatitis.N. Engl. J. Med.2016375201972198110.1056/NEJMra150520227959604
     [Google Scholar]
  4. PetrovM.S. ShanbhagS. ChakrabortyM. PhillipsA.R.J. WindsorJ.A. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis.Gastroenterology2010139381382010.1053/j.gastro.2010.06.01020540942
     [Google Scholar]
  5. AgarwalS. GeorgeJ. PadhanR.K. VadirajaP.K. BeheraS. HasanA. DhingraR. Shalimar GargP.K. Reduction in mortality in severe acute pancreatitis: A time trend analysis over 16 years.Pancreatology201616219419910.1016/j.pan.2016.01.01226915280
     [Google Scholar]
  6. CapursoG. ZerboniG. SignorettiM. ValenteR. StiglianoS. PiciucchiM. Delle FaveG. Role of the gut barrier in acute pancreatitis.J. Clin. Gastroenterol.201246Suppl.S46S5110.1097/MCG.0b013e318265209622955357
     [Google Scholar]
  7. RahmanS.H. AmmoriB.J. HolmfieldJ. LarvinM. McMahonM.J. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis.J. Gastrointest. Surg.200371263610.1016/S1091‑255X(02)00090‑212559182
     [Google Scholar]
  8. TurnerJ.R. Intestinal mucosal barrier function in health and disease.Nat. Rev. Immunol.200991179980910.1038/nri265319855405
     [Google Scholar]
  9. IacuboviciL. KarolD. BaarY. BeriA. HerzbergH. ZarourS. GorenO. CohenB. Assessment of intra-abdominal pressure with a novel continuous bladder pressure monitor-A clinical validation study.Life202313238410.3390/life1302038436836741
     [Google Scholar]
  10. LiuH. LiW. WangX. LiJ. YuW. Early gut mucosal dysfunction in patients with acute pancreatitis.Pancreas200836219219610.1097/MPA.0b013e31815a399f18376312
     [Google Scholar]
  11. GeP. LuoY. OkoyeC.S. ChenH. LiuJ. ZhangG. XuC. ChenH. Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: A troublesome trio for acute pancreatitis.Biomed. Pharmacother.202013211077010.1016/j.biopha.2020.11077033011613
     [Google Scholar]
  12. HinesO.J. PandolS.J. Management of severe acute pancreatitis.BMJ2019367l622710.1136/bmj.l622731791953
     [Google Scholar]
  13. NeoptolemosJ.P. RaratyM. FinchM. SuttonR. Acute pancreatitis: The substantial human and financial costs.Gut199842688689110.1136/gut.42.6.8869691932
     [Google Scholar]
  14. ZhuF. YinS. ZhouL. LiZ. YanH. ZhongY. WuX. LuoB. YangL. GanD. DengL. CheD. LiL. Chinese herbal medicine Xuebijing injection for acute pancreatitis: An overview of systematic reviews.Front. Pharmacol.20221388372910.3389/fphar.2022.88372936034818
     [Google Scholar]
  15. FangJ. WeiH. SunY. ZhangX. LiuW. ChangQ. WangR. GongY. Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule).BMC Complement. Altern. Med.20131317610.1186/1472‑6882‑13‑7623560927
     [Google Scholar]
  16. YangC. WangT. ChenJ. HeJ. LiY. ChenC. LuG. ChenW. Traditional Chinese medicine formulas alleviate acute pancreatitis.Pancreas202150101348135610.1097/MPA.000000000000193135041332
     [Google Scholar]
  17. LingC. YueX. LingC. Three advantages of using traditional Chinese medicine to prevent and treat tumor.J. Integr. Med.201412433133510.1016/S2095‑4964(14)60038‑825074882
     [Google Scholar]
  18. XiaoM. TianJ. ZhouY. XuX. MinX. LvY. PengM. ZhangY. YanD. LangS. ZhangQ. FanA. KeJ. LiX. LiuB. JiangM. LiuQ. ZhuJ. YangL. ZhuZ. ZengK. LiC. ZhengY. WuH. LinJ. LianF. LiX. TongX. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial.Pharmacol. Res.202016110512610.1016/j.phrs.2020.10512632781283
     [Google Scholar]
  19. LuoE. ZhangD. LuoH. LiuB. ZhaoK. ZhaoY. BianY. WangY. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): An empirical study from Wuhan, Hubei province, China.Chin. Med.20201513410.1186/s13020‑020‑00317‑x32308732
     [Google Scholar]
  20. YangZ. LiuY. WangL. LinS. DaiX. YanH. GeZ. RenQ. WangH. ZhuF. WangS. Traditional Chinese medicine against COVID-19: Role of the gut microbiota.Biomed. Pharmacother.202214911278710.1016/j.biopha.2022.11278735279010
     [Google Scholar]
  21. LiJ. ZhangS. ZhouR. ZhangJ. LiZ.F. Perspectives of traditional Chinese medicine in pancreas protection for acute pancreatitis.World J. Gastroenterol.201723203615362310.3748/wjg.v23.i20.361528611514
     [Google Scholar]
  22. WangG. ShangD. ZhangG. ZhangS. JiangN. LiuH. ChenH. Effects of QingYi decoction on inflammatory markers in patients with acute pancreatitis: A meta- analysis.Phytomedicine20229515373810.1016/j.phymed.2021.15373834544631
     [Google Scholar]
  23. WangG.Y. ShangD. ZhangG.X. SongH.Y. JiangN. LiuH.H. ChenH.L. Qingyi decoction attenuates intestinal epithelial cell injury via the calcineurin/nuclear factor of activated T-cells pathway.World J. Gastroenterol.202228293825383710.3748/wjg.v28.i29.382536157544
     [Google Scholar]
  24. ZhangJ.W. ZhangG.X. ChenH.L. LiuG.L. OwusuL. WangY.X. WangG.Y. XuC.M. Therapeutic effect of Qingyi decoction in severe acute pancreatitis-induced intestinal barrier injury.World J. Gastroenterol.201521123537354610.3748/wjg.v21.i12.353725834318
     [Google Scholar]
  25. SyedR.U. MoniS.S. LilaA.S.A. AbdallahM.H. AbouziedA.S. BanuH. AlreshidiK.S.M. AlrashidiB.M.W. HadiM.A. El-HoranyH. AbdelwahabS.I. TahaM.M.E. Spectral analysis and antiulcer potential of Lactuca sativa through the amelioration of proinflammatory cytokines and apoptosis markers.Life20221210164110.3390/life1210164136295076
     [Google Scholar]
  26. BindeaG. MlecnikB. HacklH. CharoentongP. TosoliniM. KirilovskyA. FridmanW.H. PagèsF. TrajanoskiZ. GalonJ. ClueGO: A cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks.Bioinformatics20092581091109310.1093/bioinformatics/btp10119237447
     [Google Scholar]
  27. LeppäniemiA. TolonenM. TarasconiA. Segovia-LohseH. GamberiniE. KirkpatrickA.W. BallC.G. ParryN. SartelliM. WolbrinkD. van GoorH. BaiocchiG. AnsaloniL. BifflW. CoccoliniF. Di SaverioS. KlugerY. MooreE. CatenaF. 2019 WSES guidelines for the management of severe acute pancreatitis.World J. Emerg. Surg.20191412710.1186/s13017‑019‑0247‑031210778
     [Google Scholar]
  28. CazacuS. ParscoveanuM. CartuD. MoraruE. RogoveanuI. UngureanuB. IordacheS. FlorescuD. IovanescuV. DragomirM. NLR48 is better Than CRP, and mCTSI, and similar to BISAP and SOFA scores for mortality prediction in acute pancreatitis: A comparison of 6 scores.J. Inflamm. Res.2023164793480410.2147/JIR.S43240837881651
     [Google Scholar]
  29. ChoiY.H. JangD.K. LeeS.H. JangS. ChoiJ.H. KangJ. PaikW.H. LeeJ.K. RyuJ.K. KimY.T. Utility of serum phosphate as a marker for predicting the severity of post-endoscopic retrograde cholangiopancreatography pancreatitis.United European Gastroenterol. J.20186689590110.1177/205064061876416830023067
     [Google Scholar]
  30. HuangZ. MaX. JiaX. WangR. LiuL. ZhangM. WanX. TangC. HuangL. Prevention of severe acute pancreatitis with cyclooxygenase-2 inhibitors: A randomized controlled clinical trial.Am. J. Gastroenterol.2020115347348010.14309/ajg.000000000000052932142484
     [Google Scholar]
  31. HolaniR. BabbarA. BlythG.A.D. LopesF. JijonH. McKayD.M. HollenbergM.D. CoboE.R. Cathelicidin-mediated lipopolysaccharide signaling via intracellular TLR4 in colonic epithelial cells evokes CXCL8 production.Gut Microbes2020121178580210.1080/19490976.2020.178580232658599
     [Google Scholar]
  32. MaheshwariA. LacsonA. LuW. FoxS.E. BarleycornA.A. ChristensenR.D. CalhounD.A. Interleukin-8/CXCL8 forms an autocrine loop in fetal intestinal mucosa.Pediatr. Res.200456224024910.1203/01.PDR.0000133196.25949.9815181190
     [Google Scholar]
  33. LinW.S. ChuehT.L. NagabhushanamK. HoC.T. PanM.H. Piceatannol and 3′-hydroxypterostilbene alleviate inflammatory bowel disease by maintaining intestinal epithelial integrity and regulating gut microbiota in mice.J. Agric. Food Chem.20237141994200510.1021/acs.jafc.2c0817036688924
     [Google Scholar]
  34. TianR. TanJ.T. WangR.L. XieH. QianY.B. YuK.L. The role of intestinal mucosa oxidative stress in gut barrier dysfunction of severe acute pancreatitis.Eur. Rev. Med. Pharmacol. Sci.201317334935523426538
     [Google Scholar]
  35. BaiY. LiuY. JiaL. JiangH. JiM. LvN. HuangK. ZouX. LiY. TangC. GuoX. PengX. FangD. WangB. YangB. WangL. LiZ. Severe acute pancreatitis in China: Etiology and mortality in 1976 patients.Pancreas200735323223710.1097/MPA.0b013e3180654d2017895843
     [Google Scholar]
  36. Van AckerG.J.D. WeissE. SteerM.L. PeridesG. Cause-effect relationships between zymogen activation and other early events in secretagogue-induced acute pancreatitis.Am. J. Physiol. Gastrointest. Liver Physiol.20072926G1738G174610.1152/ajpgi.00543.200617332471
     [Google Scholar]
  37. GargP.K. SinghV.P. Organ failure due to systemic injury in acute pancreatitis.Gastroenterology201915672008202310.1053/j.gastro.2018.12.04130768987
     [Google Scholar]
  38. PapachristouG.I. Prediction of severe acute pancreatitis: Current knowledge and novel insights.World J. Gastroenterol.200814416273627510.3748/wjg.14.627319009638
     [Google Scholar]
  39. WhitcombD.C. Acute pancreatitis.N. Engl. J. Med.2006354202142215010.1056/NEJMcp05495816707751
     [Google Scholar]
  40. HabtezionA. GukovskayaA.S. PandolS.J. Acute pancreatitis: A multifaceted set of organelle and cellular interactions.Gastroenterology201915671941195010.1053/j.gastro.2018.11.08230660726
     [Google Scholar]
  41. SamuelI. Bile and pancreatic juice exclusion activates acinar stress kinases and exacerbates gallstone pancreatitis.Surgery2008143343444010.1016/j.surg.2007.06.00418291265
     [Google Scholar]
  42. DingL. ChenH.Y. WangJ.Y. XiongH.F. HeW.H. XiaL. LuN.H. ZhuY. Severity of acute gastrointestinal injury grade is a good predictor of mortality in critically ill patients with acute pancreatitis.World J. Gastroenterol.202026551452310.3748/wjg.v26.i5.51432089627
     [Google Scholar]
  43. LiaoR. XueL. QiangZ. ZhangC. LiuY. Release of endogenous hydrogen sulfide in enteric nerve cells suppresses intestinal motility during severe acute pancreatitis.Acta Biochim. Biophys. Sin.2019521647110.1093/abbs/gmz13931889183
     [Google Scholar]
  44. AmmoriB.J. Role of the gut in the course of severe acute pancreatitis.Pancreas200326212212910.1097/00006676‑200303000‑0000612604908
     [Google Scholar]
  45. LiX.Y. HeC. ZhuY. LuN.H. Role of gut microbiota on intestinal barrier function in acute pancreatitis.World J. Gastroenterol.202026182187219310.3748/wjg.v26.i18.218732476785
     [Google Scholar]
  46. LuQ.G. ZengL. LiX.H. LiuY. DuX.F. BaiG.M. YanX. Protective effects of panax notoginseng saponin on dextran sulfate sodium-induced colitis in rats through phosphoinositide-3-kinase protein kinase B signaling pathway inhibition.World J. Gastroenterol.202026111156117110.3748/wjg.v26.i11.115632231420
     [Google Scholar]
  47. EscobarJ. PeredaJ. ArduiniA. SandovalJ. SabaterL. AparisiL. López-RodasG. SastreJ. Cross-talk between oxidative stress and pro-inflammatory cytokines in acute pancreatitis: A key role for protein phosphatases.Curr. Pharm. Des.200915263027304210.2174/13816120978905807519754377
     [Google Scholar]
  48. ZhongkaiL. JianxinY. WeichangC. Vasoactive intestinal peptide promotes gut barrier function against severe acute pancreatitis.Mol. Biol. Rep.20123943557356310.1007/s11033‑011‑1129‑z21725849
     [Google Scholar]
  49. GuoN.K. SheH. TanL. ZhouY.Q. TangC.Q. PengX.Y. MaC.H. LiT. LiuL.M. Nano parthenolide improves intestinal barrier function of sepsis by inhibiting apoptosis and ROS via 5-HTR2A.Int. J. Nanomedicine20231869370910.2147/IJN.S39454436816330
     [Google Scholar]
  50. LiH. XieJ. GuoX. YangG. CaiB. LiuJ. YueM. TangY. WangG. ChenS. GuoJ. QiX. WangD. ZhengH. LiuW. YuH. WangC. ZhuS.J. GuoF. Bifidobacterium spp. and their metabolite lactate protect against acute pancreatitis via inhibition of pancreatic and systemic inflammatory responses.Gut Microbes2022141212745610.1080/19490976.2022.212745636195972
     [Google Scholar]
  51. KoradaS.K. YarlaN.S. BishayeeA. AlievG. Aruna LakshmiK. ArunasreeM.K. DananajayaB.L. MishraV. Can probiotics cure inflammatory bowel diseases?Curr. Pharm. Des.201622790491710.2174/138161282266615120915324926648465
     [Google Scholar]
  52. SongG. LiuD. GengX. MaZ. WangY. XieW. QianD. MengH. ZhouB. SongZ. Bone marrow-derived mesenchymal stem cells alleviate severe acute pancreatitis-induced multiple-organ injury in rats via suppression of autophagy.Exp. Cell Res.2019385211167410.1016/j.yexcr.2019.11167431678171
     [Google Scholar]
  53. BesselinkM.G.H. van SantvoortH.C. BuskensE. BoermeesterM.A. van GoorH. TimmermanH.M. NieuwenhuijsV.B. BollenT.L. van RamshorstB. WittemanB.J.M. RosmanC. PloegR.J. BrinkM.A. SchaapherderA.F.M. DejongC.H.C. WahabP.J. van LaarhovenC.J.H.M. van der HarstE. van EijckC.H.J. CuestaM.A. AkkermansL.M.A. GooszenH.G. Dutch acute pancreatitis study group. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet2008371961365165910.1016/S0140‑6736(08)60207‑X18279948
     [Google Scholar]
  54. TennerS BaillieJ DewittJ American college of gastroenterology guideline: Management of acute pancreatitis.Am J Gastroenterol201310891400150010.1038/ajg.2013.218
     [Google Scholar]
  55. SchizodimosT. SoulountsiV. IasonidouC. KapravelosN. An overview of management of intracranial hypertension in the intensive care unit.J. Anesth.202034574175710.1007/s00540‑020‑02795‑732440802
     [Google Scholar]
  56. RahimiR.S. SingalA.G. CuthbertJ.A. RockeyD.C. Lactulose vs. polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: The HELP randomized clinical trial.JAMA Intern. Med.2014174111727173310.1001/jamainternmed.2014.474625243839
     [Google Scholar]
  57. SchmidtB.M. RibnickyD.M. LipskyP.E. RaskinI. Revisiting the ancient concept of botanical therapeutics.Nat. Chem. Biol.20073736036610.1038/nchembio0707‑36017576417
     [Google Scholar]
  58. ChenW. YangX. HuangL. XueP. WanM. GuoJ. ZhuL. JinT. HuangZ. ChenG. TangW. XiaQ. Qing-Yi decoction in participants with severe acute pancreatitis: A randomized controlled trial.Chin. Med.20151011110.1186/s13020‑015‑0039‑826029248
     [Google Scholar]
  59. WeiT.F. ZhaoL. HuangP. HuF.L. JiaoJ.Y. XiangK.L. WangZ.Z. QuJ.L. ShangD. Qing-Yi decoction in the treatment of acute pancreatitis: An integrated approach based on chemical profile, network pharmacology, molecular docking and experimental evaluation.Front. Pharmacol.20211259099410.3389/fphar.2021.59099433995005
     [Google Scholar]
  60. ErginE. OruçN. ErsözG. TekeşinO. ÖzütemizÖ. Prognosis and risk factors of ERCP pancreatitis in elderly.Sci. Rep.20211111593010.1038/s41598‑021‑95484‑834354184
     [Google Scholar]
  61. MarieS. AlhejjiK.A. Bin GheshayanS. Bin NafesahS. Al SelaimN. Dual bowel obstruction: A rare case of gallstone ileus and colonic adenocarcinoma.Cureus2022141e2137910.7759/cureus.2137935198291
     [Google Scholar]
  62. ReisnerR.M. CohenJ.R. Gallstone ileus: A review of 1001 reported cases.Am. Surg.19946064414468198337
     [Google Scholar]
  63. SapciI. HameedI. CeylanA. OktemA. RencuzogullariA. HullT.L. LiskaD. DelaneyC.P. GorgunE. Predictors of ileus following colorectal resections.Am. J. Surg.2020219352752910.1016/j.amjsurg.2019.10.00231604485
     [Google Scholar]
  64. LuZ. ChenX. GeH. LiM. FengB. WangD. GuoF. Neutrophil-lymphocyte ratio in patients with hypertriglyceridemic pancreatitis predicts persistent organ failure.Gastroenterol. Res. Pract.202220221810.1155/2022/833379435340692
     [Google Scholar]
  65. MattaB. GougolA. GaoX. ReddyN. TalukdarR. KochharR. GoenkaM.K. GullaA. GonzalezJ.A. SinghV.K. FerreiraM. StevensT. BarbuS.T. NawazH. GutierrezS.C. ZarnescuN.O. CapursoG. EaslerJ. TriantafyllouK. Pelaez-LunaM. ThakkarS. OcampoC. de-MadariaE. CoteG.A. WuB.U. ParagomiP. PothoulakisI. TangG. PapachristouG.I. Worldwide variations in demographics, management, and outcomes of acute pancreatitis.Clin. Gastroenterol. Hepatol.202018715671575.e210.1016/j.cgh.2019.11.01731712075
     [Google Scholar]
  66. MayerJ. RauB. GansaugeF. BegerH.G. Inflammatory mediators in human acute pancreatitis: Clinical and pathophysiological implications.Gut200047454655210.1136/gut.47.4.54610986216
     [Google Scholar]
  67. ChenK.L. LvZ.Y. YangH.W. LiuY. LongF.W. ZhouB. SunX.F. PengZ.H. ZhouZ.G. LiY. Effects of tocilizumab on experimental severe acute pancreatitis and associated acute lung injury.Crit. Care Med.2016448e664e67710.1097/CCM.000000000000163926963319
     [Google Scholar]
  68. GiovannoniF. QuintanaF.J. The role of astrocytes in CNS inflammation.Trends Immunol.202041980581910.1016/j.it.2020.07.00732800705
     [Google Scholar]
  69. MukaidaN. HaradaA. MatsushimaK. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions.Cytokine Growth Factor Rev.19989192310.1016/S1359‑6101(97)00022‑19720753
     [Google Scholar]
  70. García-MarchenaN. AraosP.F. BarriosV. Sánchez-MarínL. ChowenJ.A. PedrazM. Castilla-OrtegaE. Romero-SanchizP. PonceG. GavitoA.L. DecaraJ. SilvaD. TorrensM. ArgenteJ. RubioG. SerranoA. de FonsecaF.R. PavónF.J. Plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity.Front. Psychiatry2017721410.3389/fpsyt.2016.0021428149283
     [Google Scholar]
  71. van den BergF.F. KempeneersM.A. van SantvoortH.C. ZwindermanA.H. IssaY. BoermeesterM.A. Meta-analysis and field synopsis of genetic variants associated with the risk and severity of acute pancreatitis.BJS Open20204131510.1002/bjs5.5023132011822
     [Google Scholar]
  72. ZhouQ. XiangH. LiuH. QiB. ShiX. GuoW. ZouJ. WanX. WuW. WangZ. LiuW. XiaS. ShangD. Emodin alleviates intestinal barrier dysfunction by inhibiting apoptosis and regulating the immune response in severe acute pancreatitis.Pancreas20215081202121110.1097/MPA.000000000000189434714285
     [Google Scholar]
  73. TaiW.P. LinX.C. LiuH. WangC.H. WuJ. ZhangN.W. ChenW. A retrospective research of the characteristic of hypertriglyceridemic pancreatitis in Beijing, China.Gastroenterol. Res. Pract.201620161410.1155/2016/626309526880892
     [Google Scholar]
  74. ZhengY. ZhouZ. LiH. LiJ. LiA. MaB. ZhangT. LiaoQ. YeY. ZhangZ. YangY. WangZ. ZhangZ. YangJ. LiF. A multicenter study on etiology of acute pancreatitis in Beijing during 5 years.Pancreas201544340941410.1097/MPA.000000000000027325438072
     [Google Scholar]
  75. CaoL. ChenY. LiuS. HuangW. WuD. HongD. WangZ. SunY. QinK. GuoF. LuoC. JiaoQ. LuoX. ZhouJ. LiG. YeB. ChenT. LiuM. MaoW. WangL. LiS. WindsorJ.A. LiuY. KeL. TongZ. LiW. SongJ. ZengQ. GuW. ChenW. XuQ. ChenG. LiY. ZhaoL. ShiS. YaoW. HuangX. NiH. ZhouD. ChenM. ChenY. HuangM. LiB. LinJ. LuM. SunJ. XinK. HeC. YaoH. ZhuZ. ShaoF. ZhouY. LuoG. ChenX. ZhaoX. ZhaoW. FuL. TuS. XueB. LinY. PanX. WanY. ZhuQ. ChenM. LiK. MeiH. LiD. RenL. ZhangG. ShaoM. ZhaoD. ChenZ. HeW. LvN. XiaL. ZhuY. LiQ. XiaH. YangD. ZhouS. LuW. WuJ. ZhouF. LinJ. FengQ. YangM. GaoH. XuS. YuL. WuB. YeH. LiuZ. TuJ. YangH. Chinese acute pancreatitis clinical trials group (CAPCTG). Early plasmapheresis among patients with hypertriglyceridemia-associated acute pancreatitis.JAMA Netw. Open202366e232080210.1001/jamanetworkopen.2023.2080237378979
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128319149240812103715
Loading
Network Pharmacology Analysis and Retrospective Cohort Study Revealing the Effect of Qingyi Decoction on Intestinal Paralysis in Patients with Severe Acute Pancreatitis
Curr. Pharm. Des. 30, 3322 (2024); https://doi.org/10.2174/0113816128319149240812103715
/content/journals/cpd/10.2174/0113816128319149240812103715
/content/journals/cpd/10.2174/0113816128319149240812103715
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): inflammation; intestinal paralysis; molecular docking; network pharmacology; Qingyi decoction; Severe acute pancreatitis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test